A Study to Determine the Preferred Dose of the Drug, Lisinopril, for Preventing Urinary Toxicity Following Radiotherapy for Prostate Cancer
University of Rochester
University of Rochester
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
CHU de Quebec-Universite Laval
CHU de Quebec-Universite Laval
University of Aarhus
Umeå University
University of Alabama at Birmingham
University of Leeds
University of Miami
Radiation Therapy Oncology Group
Wake Forest University Health Sciences
Asan Medical Center
Case Comprehensive Cancer Center
Southlake Regional Health Centre
Lancashire Teaching Hospitals NHS Foundation Trust
National Cancer Institute (NCI)
Radiation Therapy Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Arizona